Data Fabrics in Pharma: Connecting Data for Better Decisions Blog Data Fabrics in Pharma: Connecting Data for Better Decisions Learn how a data fabric in pharma connects siloed systems. Explore the benefits of data…CertaraMarch 31, 2026
Pinnacle 21 Community vs Enterprise: Watch the webinar to decide what’s right for your study On-Demand Webinar Pinnacle 21 Community vs Enterprise: Watch the webinar to decide what’s right for your study Watch the Pinnacle 21 Community vs Enterprise webinar to learn key considerations for validation approaches…CertaraMarch 27, 2026
How Bayesian Design Is Reshaping Clinical Development Press CoverageVideo How Bayesian Design Is Reshaping Clinical Development Learn how Bayesian design is reshaping clinical trials with adaptive methods that improve efficiency, reduce…CertaraMarch 27, 2026
Where Did the 80-125% Bioequivalence Criteria Come From? BlogKnowledge Base Where Did the 80-125% Bioequivalence Criteria Come From? Discover what bioequivalence criteria mean, why the 80-125% bioequivalence range is used, and how custom…CertaraMarch 27, 2026
Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection Case Study Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection PK/PD Modeling for CNS drug development using Phoenix NLME and machine learning for better CNS…CertaraMarch 26, 2026
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics Publication Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics This review article examines the development of radiopharmaceutical imaging agents and radioligand therapies for pediatric…CertaraMarch 26, 2026
Shaping the Future of Medical Writing: Key Themes for 2026 Blog Shaping the Future of Medical Writing: Key Themes for 2026 Five key themes and their implications for leaders shaping their Medical Writing strategy for 2026CertaraMarch 26, 2026
The Next Lap in Global Regulatory Submission Speed: Advanced Approaches to Excellence and Acceleration eBook The Next Lap in Global Regulatory Submission Speed: Advanced Approaches to Excellence and Acceleration Discover advanced regulatory writing strategies, global regulatory submission best practices, eCTD guidance, ICH M15 updates…CertaraMarch 26, 2026
Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation On-Demand Webinar Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation Learn how early-stage biosimulation and mechanistic modeling enable smarter portfolio prioritization before IND-enabling studies. Watch…CertaraMarch 25, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors Publication An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors This publication highlights how pharmacometric modeling, supported by Certara, was used to inform dose selection…CertaraMarch 25, 2026